TransMedics to Present at the Cowen 41st Annual Healthcare Conference

Rhea-AI Summary

TransMedics Group (Nasdaq: TMDX), a leader in organ transplant technology, will present at the Cowen 41st Annual Healthcare Conference on March 3, 2021, at 3:20 p.m. EST. The virtual presentation aims to showcase their advancements in organ preservation and assessment, addressing the critical need for improved organ availability for transplantation. A live and archived webcast will be accessible via the TransMedics Investors website. Founded in Andover, Mass., TransMedics focuses on enhancing the viability of donor organs for patients with end-stage heart, lung, and liver failure.

News Market Reaction – TMDX

+9.57%

+9.57% Session move

In the trading session that priced this news, TMDX gained 9.57%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., Feb. 16, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that members of the management team will present virtually at the upcoming Cowen 41^st Annual Healthcare Conference. Management is scheduled to present on Wednesday, March 3, 2021 at 3:20 p.m. Eastern Standard Time.

Event: Cowen 41st Annual Healthcare Conference
Date: Wednesday, March 3, 2021
Time: 3:20 p.m. EST

A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/transmedics-to-present-at-the-cowen-41st-annual-healthcare-conference-301229193.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics presenting at the Cowen 41st Annual Healthcare Conference?

TransMedics will present on March 3, 2021, at 3:20 p.m. EST.

Where can I watch TransMedics' presentation at the Cowen Conference?

You can watch the presentation live and archived on the TransMedics Investors website.

What is the focus of TransMedics Group's technology?

TransMedics focuses on improving organ preservation and assessment for transplantation.

What stock symbol is associated with TransMedics Group?

The stock symbol for TransMedics Group is TMDX.

What is the location of TransMedics Group's headquarters?

TransMedics Group is headquartered in Andover, Massachusetts.